EU Consults on CLP Classifications for Endocrine Disruptors and Persistent Substances
Reference source : European Commission
The European Commission is seeking feedback on two draft delegated regulations amending Annex VI to the Classification, Labelling and Packaging (CLP) Regulation. The proposals concern harmonised classifications for endocrine disruptors and persistent substances, together with accompanying classification and labelling notes. Comments can be submitted until 24 November 2026.
Proposed Harmonised Classifications
The first draft would introduce new entries and amend existing entries in Annex VI for substances already identified as endocrine disruptors, persistent, bioaccumulative and toxic (PBT), or very persistent and very bioaccumulative (vPvB) under REACH, the Biocidal Products Regulation or the Plant Protection Products Regulation.
The proposal would transfer existing scientific assessments into the CLP framework, following the ‘one substance, one assessment’ principle and avoiding duplication of assessment work. Harmonised classifications would establish common classification and labelling requirements across the EU for the hazard classes covered.
Examples include proposed Category 1 endocrine disruptor classifications for both human health and the environment for bisphenol A and bisphenol S. The draft also includes PBT and vPvB classifications for several siloxanes, including D5 and D6.
The draft provides for an adaptation period of approximately 18 months before the classifications become mandatory. Suppliers would be able to apply the new requirements voluntarily from entry into force. Calendar dates will depend on adoption and publication of the final regulation.
Additional Classification and Labelling Notes
The second draft would introduce additional instructions for identifying substances and applying the harmonised classifications to substances and mixtures.
The mixture notes introduce additivity rules for specified groups of substances. Where an applicable note is assigned, concentrations of the relevant substances would be added together and compared with the relevant concentration limit when determining whether a mixture requires classification as an endocrine disruptor, PBT or vPvB.
Note Y addresses the role of octamethylcyclotetrasiloxane (D4) content in certain PBT classifications. Where a substance contains less than 0.1% D4 by weight, suppliers would need to assess its PBT classification themselves. Note Z would clarify the use of more precise substance names and identification numbers for individual substances covered by group entries.
Stakeholders can submit feedback on both drafts through the European Commission’s Have Your Say portal until 24 November 2026.